UBS’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$906K Sell
65,809
-27,808
-30% -$422K ﹤0.01% 3688
2014
Q2
$1.5M Buy
93,617
+92,929
+13,507% +$1.47M ﹤0.01% 3166
2014
Q1
$12K Sell
688
-2,491
-78% -$45.2K ﹤0.01% 8718
2013
Q4
$67K Sell
3,179
-41,577
-93% -$937K ﹤0.01% 6578
2013
Q3
$973K Buy
44,756
+13,117
+41% +$280K ﹤0.01% 3371
2013
Q2
$592K Buy
+31,639
New +$577K ﹤0.01% 3936

Other funds holding NXGN

UBS's NXGN Position: Q3 2014 in Review

UBS reduced its NextGen Healthcare, Inc. Common Stock (NXGN) stake by 30% in Q3 2014, selling an estimated $422K and leaving 65,809 shares worth $906K. The position accounts for ﹤0.01% of the portfolio, ranked #3688.

UBS first reported a position in NXGN in Q2 2013 and has held it in 6 quarters since. The position peaked at $1.5M in Q2 2014. 169 funds tracked by Wall St. Rank hold NXGN as of Q3 2014.

  • UBS held 65,809 shares of NextGen Healthcare, Inc. Common Stock worth $906K as of Q3 2014.
  • UBS sold 27,808 NextGen Healthcare, Inc. Common Stock shares in Q3 2014, an estimated $422K.
  • NextGen Healthcare, Inc. Common Stock made up ﹤0.01% of UBS's portfolio in Q3 2014, its #3688 holding.
  • UBS first reported a position in NextGen Healthcare, Inc. Common Stock in Q2 2013 and has held it in 6 quarters since.
  • UBS's NextGen Healthcare, Inc. Common Stock position peaked at $1.5M in Q2 2014.
  • 169 funds tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.